Literature DB >> 11897450

Gender differences and normal left ventricular anatomy in an adult population free of hypertension. A cardiovascular magnetic resonance study of the Framingham Heart Study Offspring cohort.

Carol J Salton1, Michael L Chuang, Christopher J O'Donnell, Michelle J Kupka, Martin G Larson, Kraig V Kissinger, Robert R Edelman, Daniel Levy, Warren J Manning.   

Abstract

OBJECTIVES: We sought to derive gender-specific cardiovascular magnetic resonance (CMR) reference values for normative left ventricular (LV) anatomy and function in a healthy adult population of clinically relevant age.
BACKGROUND: Cardiovascular magnetic resonance imaging is increasingly applied in the clinical setting, but age-relevant, gender-specific normative values are currently unavailable.
METHODS: A representative sample of 318 Framingham Heart Study (FHS) Offspring participants free of clinically overt cardiovascular disease underwent CMR examination to determine LV end-diastolic and end-systolic volume (EDV and ESV, respectively), mass, ejection fraction (EF) and linear dimensions (wall thickness, cavity length). Subjects with a clinical history of hypertension or those with a systolic blood pressure > or =140 mm Hg or diastolic pressure > or =90 mm Hg at any FHS cycle examination were excluded, leaving 142 subjects (63 men, 79 women; age 57 +/- 9 years).
RESULTS: All volumetric (EDV, ESV, mass) and unidimensional measures were significantly greater (p < 0.001) in men than in women and remained greater (p < 0.02) after adjustment for subject height. Volumetric measures were greater (p < 0.001) in men than in women after adjustment for body surface area (BSA), but there were increased linear dimensions in women after adjustment for BSA. In particular, end-diastolic dimension indexed to BSA was greater in women (p < 0.001) than in men. There were no gender differences in global LVEF (men = 0.69; women = 0.70).
CONCLUSIONS: Cardiovascular magnetic resonance measures of LV volumes, mass and linear dimensions differ significantly according to gender and body size. This study provides gender-specific normal CMR reference values, uniquely derived from a population-based sample of persons free of cardiovascular disease and clinical hypertension. These data may serve as a reference to identify LV pathology in the adult population.

Entities:  

Mesh:

Year:  2002        PMID: 11897450     DOI: 10.1016/s0735-1097(02)01712-6

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  100 in total

1.  Cardiac MRI assessed left ventricular hypertrophy in differentiating hypertensive heart disease from hypertrophic cardiomyopathy attributable to a sarcomeric gene mutation.

Authors:  Petri Sipola; Jarkko Magga; Minna Husso; Pertti Jääskeläinen; Keijo Peuhkurinen; Johanna Kuusisto
Journal:  Eur Radiol       Date:  2011-01-28       Impact factor: 5.315

Review 2.  Cardiac remodeling at the population level--risk factors, screening, and outcomes.

Authors:  Ola Gjesdal; David A Bluemke; Joao A Lima
Journal:  Nat Rev Cardiol       Date:  2011-10-25       Impact factor: 32.419

3.  Comparison of gated single-photon emission computed tomography with magnetic resonance imaging for evaluation of left ventricular volumes and ejection fraction in patients with idiopathic dilated cardiomyopathy.

Authors:  Petri Sipola; Keijo Peuhkurinen; Esko Vanninen
Journal:  Int J Cardiovasc Imaging       Date:  2010-09-28       Impact factor: 2.357

4.  Stress myocardial perfusion imaging by CMR provides strong prognostic value to cardiac events regardless of patient's sex.

Authors:  Otavio R Coelho-Filho; Luciana F Seabra; François-Pierre Mongeon; Shuaib M Abdullah; Sanjeev A Francis; Ron Blankstein; Marcelo F Di Carli; Michael Jerosch-Herold; Raymond Y Kwong
Journal:  JACC Cardiovasc Imaging       Date:  2011-08

5.  Sex, Myocardial Infarction, and the Failure of Risk Scores in Women.

Authors:  Shilpa Agrawal; Jennifer Van Eyk; Kimia Sobhani; Janet Wei; C Noel Bairey Merz
Journal:  J Womens Health (Larchmt)       Date:  2015-08-19       Impact factor: 2.681

6.  High-sensitivity cardiac troponin T and cognitive function and dementia risk: the atherosclerosis risk in communities study.

Authors:  Andrea L C Schneider; Andreea M Rawlings; A Richey Sharrett; Alvaro Alonso; Thomas H Mosley; Ron C Hoogeveen; Christie M Ballantyne; Rebecca F Gottesman; Elizabeth Selvin
Journal:  Eur Heart J       Date:  2014-03-30       Impact factor: 29.983

7.  Peri-infarct zone characterized by cardiac magnetic resonance imaging is directly associated with the inflammatory activity during acute phase myocardial infarction.

Authors:  Jose C Quinaglia e Silva; Otavio Rizzi Coelho-Filho; Joalbo M Andrade; Thiago Quinaglia; Rodrigo G P Modolo; Breno O Almeida; Rob J van der Geest; Michael Jerosch-Herold; Otavio Rizzi Coelho; Andrei C Sposito
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

8.  Comparison of biventricular dimensions and function between pediatric sickle-cell disease and thalassemia major patients without cardiac iron.

Authors:  Antonella Meloni; Jon Detterich; Vasili Berdoukas; Alessia Pepe; Massimo Lombardi; Thomas D Coates; John C Wood
Journal:  Am J Hematol       Date:  2013-02-06       Impact factor: 10.047

9.  Impact of age, sex, and indexation method on MR left ventricular reference values in the Framingham Heart Study offspring cohort.

Authors:  Susan B Yeon; Carol J Salton; Philimon Gona; Michael L Chuang; Susan J Blease; Yuchi Han; Connie W Tsao; Peter G Danias; Daniel Levy; Christopher J O'Donnell; Warren J Manning
Journal:  J Magn Reson Imaging       Date:  2014-05-12       Impact factor: 4.813

10.  A collaborative resource to build consensus for automated left ventricular segmentation of cardiac MR images.

Authors:  Avan Suinesiaputra; Brett R Cowan; Ahmed O Al-Agamy; Mustafa A Elattar; Nicholas Ayache; Ahmed S Fahmy; Ayman M Khalifa; Pau Medrano-Gracia; Marie-Pierre Jolly; Alan H Kadish; Daniel C Lee; Ján Margeta; Simon K Warfield; Alistair A Young
Journal:  Med Image Anal       Date:  2013-09-13       Impact factor: 8.545

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.